<DOC>
	<DOC>NCT00092638</DOC>
	<brief_summary>The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved cholesterol lowering medication.</brief_summary>
	<brief_title>An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)</brief_title>
	<detailed_description>The duration of treatment is 10 weeks.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patients with elevated cholesterol and coronary heart disease Patients whose cholesterol levels measure within acceptable ranges as specified by the study requirements</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Elevated Cholesterol</keyword>
</DOC>